A Real-world Study of Durvalumab for Lung Cancer in China

NCT04672759 · clinicaltrials.gov ↗

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer Stage III
Small-Cell Lung Cancer

Interventions

DRUG: Durvalumab
DRUG: Durvalumab

Sponsor

Peking Union Medical College Hospital